AVBP

ArriVent BioPharma, Inc. AVBP

NasdaqSmall CapHealthcare

13F Pro Quality Score

Not in ranked universe

Pending next ranking run

This company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. Rankings refresh on Jan 1, Apr 1, Jul 1, Oct 1.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Top Institutional Holders

as of Q2 2026
$1.60B total
SUVRETTA CAPITAL MANAGEMENT, LLC
$156.87M+2.6%
INFINITUM ASSET MANAGEMENT, LLC
$154.19M+7.0%
Hillhouse Capital Advisors, Ltd.
$136.50M0.0%
BlackRock, Inc.
$112.92M+28.5%
ORBIMED ADVISORS LLC
$105.17M0.0%
FMR LLC
$96.54M-7.9%
Octagon Capital Advisors LP
$68.47M0.0%
VANGUARD CAPITAL MANAGEMENT LLC
$61.66M+16.1%
Sofinnova Ventures Inc
$58.95M0.0%
STATE STREET CORP
$58.81M+19.1%
Vivo Capital, LLC
$58.44M+89.9%
Novo Holdings A/S
$52.11M-22.8%
General Catalyst Group Management, LLC
$51.93M0.0%
Logos Global Management LP
$34.74M+185.7%
GEODE CAPITAL MANAGEMENT, LLC
$33.80M+21.0%
D. E. Shaw & Co., Inc.
$30.29M+136.4%
GOLDMAN SACHS GROUP INC
$29.66M0.0%
SC CHINA HOLDING Ltd
$23.04M0.0%
Point72 Asset Management, L.P.
$19.69M-24.2%
MILLENNIUM MANAGEMENT LLC
$15.24M+3.0%
UBS Group AG
$15.24M-9.8%
BALYASNY ASSET MANAGEMENT L.P.
$13.74M-7.2%
AMERIPRISE FINANCIAL INC
$13.26M+112.0%
VANGUARD PORTFOLIO MANAGEMENT LLC
$11.65M+32.1%
NORTHERN TRUST CORP
$11.56M+23.8%
See all 158 institutional holders →
Reading the latest SEC filing…

Key Metrics

Net Income

Q2 2026
EDGAR

EPS (Diluted)

Q2 2026
EDGAR

ROIC

Q2 2026
EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/AVBP

Earnings Per Share

13fpro.ai/company/AVBP

Loading ratio trend…

AVBP insiders

Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.

About ArriVent BioPharma, Inc. (AVBP): stock profile, AI score and financials

ArriVent BioPharma, Inc. (AVBP) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. AVBP is not currently included in 13F Pro's AI-ranked quality universe — this company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. rankings refresh on jan 1, apr 1, jul 1, oct 1. Top institutional holders of AVBP by reported 13-F value include SUVRETTA CAPITAL MANAGEMENT, INFINITUM ASSET MANAGEMENT, Hillhouse Capital Advisors, Ltd., based on the most recent SEC filings. AVBP trades on the Nasdaq exchange and files with the SEC under CIK 1868279. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate AVBP daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for ArriVent BioPharma, Inc. directly from SEC EDGAR.

Financials through the period ended SEC EDGAR: CIK 1868279 →